Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Garry P Reams. (1996) Section Review; Cardiovascular & Renal: Calcium channel blockers for the treatment of renal disease. Expert Opinion on Investigational Drugs 5:5, pages 521-534.
Read now
Read now
Luis M. Ruilope, Alicia Araque, Vicente Lahera & Carmen Suarez. (1993) Antihypertensive Effect of Nitrendipine in the Hypertensive Patient with Renal Impairment. Renal Failure 15:3, pages 359-363.
Read now
Read now
Matthew R. Weir & George L. Bakris. (1992) Risk for renal injury in diabetic hypertensive patients. Postgraduate Medicine 91:3, pages 77-84.
Read now
Read now
H. Eiskjár, C. E. Mogensen, A. Schmitz & E. B. Pedersen. (1991) Enhanced urinary excretion of albumin and β2 microglobulin in essential hypertension induced by atrial natriuretic peptide. Scandinavian Journal of Clinical and Laboratory Investigation 51:4, pages 359-366.
Read now
Read now
Cramer K. Christensen, Lars R. Krusell & Carl Erik Mogensen. (1987) Increased blood pressure in diabetes: Essential hypertension or diabetic nephropathy?. Scandinavian Journal of Clinical and Laboratory Investigation 47:4, pages 363-370.
Read now
Read now
B. Jespersen, E. B. Pedersen, H. Danielsen, H. J. Kornerup, F. Knudsen, C. E. Mogensenf & A. H. Nielsen. (1986) Urinary excretion of albumin and beta-2-microglobulin in hypertensive and normotensive renal transplant recipients during urinary diluting and concentrating tests. Scandinavian Journal of Clinical and Laboratory Investigation 46:7, pages 609-614.
Read now
Read now
E. B. Pedersen, A. B. Rasmussen, P. Johannesen, S. Kristensen, J. G. Lauritsen, C. E. Mogensen, K. Sølling & M. Wohlert. (1981) Urinary excretion of albumin, beta-2-microglobulin and light chains in pre-eclampsia, essential hypertension in pregnancy and normotensive pregnant and non-pregnant control subjects. Scandinavian Journal of Clinical and Laboratory Investigation 41:8, pages 777-784.
Read now
Read now
E. B. Pedersen, C. E. Mogensen & J. S. Larsen. (1981) Effects of exercise on urinary excretion of albumin and β2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment. Scandinavian Journal of Clinical and Laboratory Investigation 41:5, pages 493-498.
Read now
Read now
C. E. Mogensen. (1976) Progression of Nephropathy in Long-Term Diabetics with Proteinuria and Effect of Initial Anti-Hypertensive Treatment. Scandinavian Journal of Clinical and Laboratory Investigation 36:4, pages 383-388.
Read now
Read now
Articles from other publishers (73)
Vladimír Tesař & Jan Vachek. (2017) Gliflozins slow down the progression of diabetic kidney disease. Vnitřní lékařství 63:10, pages 723-727.
Crossref
Crossref
Michelle J. Pena, Dick de Zeeuw, Harald Mischak, Joachim Jankowski, Rainer Oberbauer, Wolfgang Woloszczuk, Jacqueline Benner, Guido Dallmann, Bernd Mayer, Gert Mayer, Peter Rossing & Hiddo J. Lambers Heerspink. (2015) Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes. Nephrology Dialysis Transplantation 30:suppl 4, pages iv86-iv95.
Crossref
Crossref
George L. Bakris & Mark Molitch. (2014) Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga. Diabetes Care 37:3, pages 867-875.
Crossref
Crossref
Baris Afsar & Rengin Elsurer. (2010) Urinary albumin excretion among nondipper hypertensive patients is closely related with the pattern of nondipping. Journal of the American Society of Hypertension 4:4, pages 196-202.
Crossref
Crossref
Alfonso S. Gozalo, Alfonso Chavera, Enrique J. Montoya, Juan Takano & Richard E. Weller. (2008)
Relationship of creatine kinase, aspartate aminotransferase, lactate dehydrogenase, and proteinuria to cardiomyopathy in the owl monkey (
Aotus vociferans
)
. Journal of Medical Primatology 37:s1, pages 29-38.
Crossref
Crossref
Baek Hwan Cho, Hwanjo Yu, Kwang-Won Kim, Tae Hyun Kim, In Young Kim & Sun I. Kim. (2008) Application of irregular and unbalanced data to predict diabetic nephropathy using visualization and feature selection methods. Artificial Intelligence in Medicine 42:1, pages 37-53.
Crossref
Crossref
S Bianchi, R Bigazzi, A Amoroso & V M Campese. (2003) Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity. Journal of Human Hypertension 17:1, pages 13-20.
Crossref
Crossref
R Pedrinelli, G Dell'Omo, V Di Bello, R Pontremoli & M Mariani. (2002) Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. Journal of Human Hypertension 16:2, pages 79-89.
Crossref
Crossref
Didier Laurent, Kevin Poirier, James Wasvary & Markus Rudin. (2001) Effect of essential hypertension on kidney function as measured in rat by dynamic MRI. Magnetic Resonance in Medicine 47:1, pages 127-134.
Crossref
Crossref
Liam F. Casserly, Nelson Chow, Shaukat Ali, Daniel J. Gottlieb, Lawrence J. Epstein & James S. Kaufman. (2001) Proteinuria in obstructive sleep apnea. Kidney International 60:4, pages 1484-1489.
Crossref
Crossref
Evelyn M. Tolbert, Joseph Weisstuch, Helen D. Feiner & Lance D. Dworkin. (2000) Onset of glomerular hypertension with aging precedes injury in the spontaneously hypertensive rat. American Journal of Physiology-Renal Physiology 278:5, pages F839-F846.
Crossref
Crossref
Vito M. Campese, Stefano Bianchi & Roberto Bigazzi. (2000) Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?. Current Opinion in Nephrology and Hypertension 9:2, pages 143-147.
Crossref
Crossref
C. E. Mogensen. 2000. The Kidney and Hypertension in Diabetes Mellitus. The Kidney and Hypertension in Diabetes Mellitus
655
706
.
Vito M. Campese, Roberto Bigazzi & Stefano Bianchi. 2000. The Kidney and Hypertension in Diabetes Mellitus. The Kidney and Hypertension in Diabetes Mellitus
575
586
.
Stefano Bianchi, Roberto Bigazzi & Vito M. Campese. (1999) Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. American Journal of Kidney Diseases 34:6, pages 973-995.
Crossref
Crossref
Satoshi Hishiki, Osamu Tochikubo, Eiji Miyajima & Masao Ishii. (1998) Circadian variation of urinary microalbumin excretion and ambulatory blood pressure in patients with essential hypertension. Journal of Hypertension 16:Supplement, pages 2101-2108.
Crossref
Crossref
Søren Nielsen, Jens Dollerup, Bente Nielsen & Carl E. Mogensen. (1998) Combination of enalapril and low-dose thiazide reduces normoalbuminuria in essential hypertension. Journal of Hypertension 16:10, pages 1539-1544.
Crossref
Crossref
Roberto Bigazzi, Stefano Bianchi, Duccio Baldari & Vito M. Campese. (1998) Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. Journal of Hypertension 16:9, pages 1325-1333.
Crossref
Crossref
Peter ClausenJan S. JensenKnut Borch-JohnsenGorm JensenBo Feldt-Rasmussen. (1998) Ambulatory Blood Pressure and Urinary Albumin Excretion in Clinically Healthy Subjects. Hypertension 32:1, pages 71-77.
Crossref
Crossref
Stefano Bianchi, Roberto Bigazzi & Vito M. Campese. 1998. The Kidney and Hypertension in Diabetes Mellitus. The Kidney and Hypertension in Diabetes Mellitus
569
584
.
Klavs W. Hansen. (1996) Ambulatory blood pressure in insulin-dependent diabetes: The relation to stages of diabetic kidney disease. Journal of Diabetes and its Complications 10:6, pages 331-351.
Crossref
Crossref
Jacob Bar, Moshe Hod, Arie Erman, Samuel Friedman, Ilana Gelerenter, Boris Kaplan, Geoffrey Boner & Jardena Ovadia. (1996) Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. American Journal of Kidney Diseases 28:2, pages 220-225.
Crossref
Crossref
Stefan Heidenreich, Edmund Zierden & Walter Zidek. (1995) Microalbuminuria in very old patients. Geriatric Nephrology and Urology 5:1, pages 9-13.
Crossref
Crossref
B N Panayiotou. (2016) Microalbuminuria: Pathogenesis, Prognosis and Management. Journal of International Medical Research 22:4, pages 181-201.
Crossref
Crossref
A HøegholmL E BangK S KristensenJ W NielsenJ Holm. (1994) Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension.. Hypertension 24:1, pages 101-105.
Crossref
Crossref
C. E. Mogensen. (2009) Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. Journal of Internal Medicine 235:4, pages 297-316.
Crossref
Crossref
Thomas E.R. Brown & Barry L. Carter. (2016) Hypertension and Endstage Renal Disease. Annals of Pharmacotherapy 28:3, pages 359-366.
Crossref
Crossref
R BigazziS BianchiD BaldariG SgherriG BaldariV M Campese. (1994) Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.. Hypertension 23:2, pages 195-199.
Crossref
Crossref
Joseph Konen, Zakariya Shihabi & Jeffrey Newman. (1993) The Association of Non-Insulin-Dependent Diabetes Mellitus and Hypertension With Urinary Excretion of Albumin and Transferrin. American Journal of Kidney Diseases 22:6, pages 791-797.
Crossref
Crossref
Leo Niskanen & Markku Laakso. (1993) Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 42:12, pages 1541-1545.
Crossref
Crossref
C M ErleyU HaefeleN HeyneN BraunT Risler. (1993) Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs.. Hypertension 21:6_pt_1, pages 810-815.
Crossref
Crossref
Neale Cohen, Paddy Phillips, Richard Gilbert & George Jerums. (2007) DISSOCIATION OF BLOOD PRESSURE AND ALBUMINURIA IN NORMAL SUBJECTS INFUSED WITH ANGIOTENSIN II AND NORADRENALINE. Clinical and Experimental Pharmacology and Physiology 20:5, pages 317-319.
Crossref
Crossref
Vito M. Campese, Frederick Karubian & Roberto Bigazzi. (1993) Hemodynamic Alterations and Urinary Albumin Excretion in Patients With Essential Hypertension. American Journal of Kidney Diseases 21:5, pages 15-21.
Crossref
Crossref
William McClellan. (1993) Hypertensive End-Stage Renal Disease in Blacks: The Role of End-Stage Renal Disease Surveillance. American Journal of Kidney Diseases 21:4, pages 25-30.
Crossref
Crossref
Andrea Giustina, Simonetta Bossoni, Claudio Macca & Giuseppe Romanelli. (2009) Isradipine Decreases Exercise-Induced Albuminuria in Patients with Essential Hypertension. Renal Failure 15:4, pages 509-514.
Crossref
Crossref
E. Brändle, E. Gottwald, H. Melzer & H. G. Sieberth. (1992) Influence of oral contraceptive agents on kidney function and protein metabolism. European Journal of Clinical Pharmacology 43:6, pages 643-646.
Crossref
Crossref
Stefano Bianchi, Roberto Bigazzi, Giorgio Baldari & Vito M. Campese. (1992) Microalbuminuria in patients with essential hypertension: Effects of several antihypertensive drugs. The American Journal of Medicine 93:5, pages 525-528.
Crossref
Crossref
O. Samuelsson, T. Hedner, S. Ljungman, H. Herlitz, B. Widgren & K. Pennert. (1992) A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension. European Journal of Clinical Pharmacology 43:5, pages 469-475.
Crossref
Crossref
Albert A. Carr, P. Bruce Bottini & L. Michael Prisant. (2013) Ambulatory Blood Pressure Monitoring for Evaluation and Management of Hypertensives: Effect on Outcome and Cost Effectiveness. The Journal of Clinical Pharmacology 32:7, pages 610-613.
Crossref
Crossref
P Martin, H Tindall, J N Harvey, T M Handley, C Chapman & J A Davies. (2016) Glomerular and Tubular Proteinuria in Type 1 (Insulin-Dependent) Diabetic Patients with and without Retinopathy. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 29:3, pages 265-270.
Crossref
Crossref
B. PERSSON, O. K. ANDERSSON, M. WYSOCKI, T. HEDNER & B. KARLBER. (2009) Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria. Journal of Internal Medicine 231:3, pages 247-252.
Crossref
Crossref
John H. Bauer & Garry P. Reams. (2014) ACE inhibitors in renal disease. Clinical Cardiology 14:S4, pages 38-43.
Crossref
Crossref
John H. Bauer, Garry P. Reams & Zhen Wu. (1991) The aging hypertensive kidney: Pathophysiology and therapeutic options. The American Journal of Medicine 90:4, pages S21-S27.
Crossref
Crossref
J. H. Bauer & G. P. Reams. 1991. Endorganschädigungen der arteriellen Hypertonie — Konsequenzen für Diagnostik und Therapie. Endorganschädigungen der arteriellen Hypertonie — Konsequenzen für Diagnostik und Therapie
145
161
.
Garry P. Reams & John H. Bauer. (1990) Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney. Cardiovascular Drugs and Therapy 4:1, pages 207-219.
Crossref
Crossref
M. Ardon, I.A. Macfarlane, P. Martin, C. Walton, J. Day, C. Robinson & P. Calverly. (1989) Urinary excretion of albumin, α-1-microglobulin, and N-acetyl-B-D-glucosaminidase in relation to smoking habits in diabetic and nondiabetic subjects. Journal of Diabetic Complications 3:3, pages 154-157.
Crossref
Crossref
JohnS. Yudkin, RichardD. Forrest & CarolineA. Jackson. (1988) MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS. The Lancet 332:8610, pages 530-533.
Crossref
Crossref
G. F. Watts, B. Hodgson, R. W. Morris, K. M. Shaw & A. Polak. (2009) Side‐room Tests to Screen for Micro‐albuminuria in Diabetes Mellitus. Diabetic Medicine 5:3, pages 298-303.
Crossref
Crossref
Javier Narvarte, Myriam Privé, Sabiha R. Saba & German Ramirez. (1987) Proteinuria in Hypertension. American Journal of Kidney Diseases 10:6, pages 408-416.
Crossref
Crossref
B W Hodgson & G F Watts. (2016) A Simple Side-Room Test to Screen for ‘Microalbuminuria’ in Diabetes Mellitus. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 24:6, pages 581-584.
Crossref
Crossref
A. Chachati, R. von Frenckell, J. Foidart‐Willems, J.P. Godon & P.J. Lefebvre. (2009) Variability of Albumin Excretion in Insulin‐dependent Diabetics. Diabetic Medicine 4:5, pages 441-445.
Crossref
Crossref
C.K. Christensen & C.E. Mogensen. (1987) Antihypertensive treatment: Long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. Journal of Diabetic Complications 1:2, pages 45-52.
Crossref
Crossref
C.E. Mogensen. (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney International 31:2, pages 673-689.
Crossref
Crossref
G F Watts, J D Albano, J E Bennett, R W Morris, K M Shaw & A Polak. (1986) Assessment of new radioimmunoassay kit for determining urinary albumin at low concentrations: comparison with radial immunodiffusion.. Journal of Clinical Pathology 39:10, pages 1151-1154.
Crossref
Crossref
H H Parving, A R Andersen, E Hommel & U Smidt. (1985) Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.. Hypertension 7:6_pt_2.
Crossref
Crossref
C K Christensen & C E Mogensen. (1985) Effect of antihypertensive treatment on progression of incipient diabetic nephropathy.. Hypertension 7:6_pt_2.
Crossref
Crossref
David S. Baldwin & Joel Neugarten. (1985) Treatment of Hypertension in Renal Disease. American Journal of Kidney Diseases 5:4, pages A57-A70.
Crossref
Crossref
James M. Luciano, Aram V. Manoukian, Khalid M. H. Butt & Eli A. Friedman. 1985. Proteinuria. Proteinuria
107
118
.
E. G. Breen, M. Lombard, A. Watson & J. A. B. Keogh. (1984) Labetolol in patients with hypertension and varying degrees of renal impairment. Irish Journal of Medical Science 153:10, pages 336-342.
Crossref
Crossref
GianCarlo Viberti & Martin J. Wiseman. 1984. Nephrology. Nephrology
1094
1102
.
Hans-Henrik Parving, UllaM Smidt, AllanR Andersen & PerAa Svendsen. (1983) EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY. The Lancet 321:8335, pages 1175-1179.
Crossref
Crossref
Stephen C. Textor, Fetnat M. Fouad, Emmanuel L. Bravo, Robert C. Tarazi, Donald G. Vidt & Ray W. GiffordJr.Jr.. (1982) Redistribution of Cardiac Output to the Kidneys during Oral Nadolol Administration. New England Journal of Medicine 307:10, pages 601-605.
Crossref
Crossref
W. Dallas Hall & Gary L. Wollam. (1982) Systolic hypertension. Current Problems in Cardiology 7:6, pages 1-40.
Crossref
Crossref
P W de Leeuw & W H Birkenhäger. (1982) Renal response to propranolol treatment in hypertensive humans.. Hypertension 4:1, pages 125-131.
Crossref
Crossref
A. Watson, K. Maher & J. A. B. Keogh. (1981) Labetalol and renal function. Irish Journal of Medical Science 150:1, pages 174-177.
Crossref
Crossref
Takashi Yamada, Masaki Ishihara, Kazuo Ichikawa & Kunihide Hiramatsu. (2015) Proteinuria and Renal Function During Antihypertensive Treatment for Essential Hypertension. Journal of the American Geriatrics Society 28:3, pages 114-117.
Crossref
Crossref
C.E. MOGENSEN, C.K. CHRISTENSEN, N.J. CHRISTENSEN, H.J. GUNDERSEN & P. GJøde. 1980. Biochemical Aspects of Renal Function. Biochemical Aspects of Renal Function
181
184
.
C.E. Mogensen, C.K. Christensen, N.J. Christensen, H.J. Gundersen & P. Gjode. (1980) Renal protein handling in man, modified by insulin administration, stress situations and hypertension. International Journal of Biochemistry 12:1-2, pages 181-184.
Crossref
Crossref
Giuseppe Bianchi, Daniele Cusi, Cristina Barlassina, Liliana Duzzi, Anna M. Caravaggi, Gianpietro Lupi, Massimo Gatti, Ornella Velis, Giovanna Como & Guido Salvioli. (1980) Transcapillary protein escape in arterial hypertension. La Ricerca in Clinica e in Laboratorio 10:1, pages 163-170.
Crossref
Crossref
NK Hollenberg, DF Adams, DN McKinstry, GH Williams, LJ Borucki & JM Sullivan. (2012) beta‐Adrenoceptor‐blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.. British Journal of Clinical Pharmacology 7:S2.
Crossref
Crossref
DavidH.P Streeten, M.G Dunnigan & J.R Lawrence. (1979) IDIOPATHIC ŒDEMA. The Lancet 313:8119, pages 775-777.
Crossref
Crossref
C.E. Mogensen, P. Gjøde & C.K. Christensen. (1979) ALBUMIN EXCRETION IN OPERATING SURGEONS AND IN HYPERTENSION. The Lancet 313:8119, pages 774-775.
Crossref
Crossref
Ove B. Schaffalitzky de Muckadell, Jan Fahrenkrug, Steen Watt-Boolsen & Helge Worning. (2010) Pancreatic Response and Plasma Secretin Concentration during Infusion of Low Dose Secretin in Man. Scandinavian Journal of Gastroenterology 13:3, pages 305-311.
Crossref
Crossref